Skip to main content
. 2017 Jun 14;7:3494. doi: 10.1038/s41598-017-03796-5

Figure 6.

Figure 6

Schematic overview illustrating the proposed by which CTSD participates in the development of hepatic inflammation. Based on findings of the current study, increased levels of CTSD lead to a disturbance in lipid metabolism, which is known to result in increased plasma cholesterol (hypercholesterolemia) and triglyceride (hypertriglyceridemia) levels. Consequently, hypercholesterolemia and hypertriglyceridemia can lead to hepatic inflammation.